Centre considering ban on Mephedrone alias ‘meow-meow’ drug
January 27, 2015
Mumbai
The Centre today told the Bombay High Court that Maharashtra government’s recommendation of a ban on the drug Mephedrone, also known as `meow-meow’, was under consideration.
The court was hearing a public interest litigation filed by Dr Yusuf Merchant seeking a direction to the central and state governments to conduct investigation into the nature, effects and availability of Mephedrone and consider its inclusion in the list of scheduled (banned) substances under Narcotic Drugs and Psychotropic Substances Act.
Additional government pleader H S Venegoankar said the state had already sent a proposal to the union government in this regard and was waiting for its reply.
Additional Solicitor General Anil Singh informed that this recommendation to bring the drug under the purview of NDPS Act is already under consideration.
Petitioner’s lawyer advocate V R Dhond said 53 countries have banned the drug but it is freely available in India for Rs 150-500 per gram.
According the the petitioner, the narcotic effects of Mephedrone – also known as MD, Meow Meow and M-cat — are ten times more intense than heroin.
Essentially a plant fertiliser, it is being abused, he added.
The court has directed the union and state governments to file their respective affidavits in this regard.
© Copyright PTI. All rights reserved. Republication or redistribution of any PTI content, including by framing or similar means, is expressly prohibited without their prior written consent.
Recent Stories
- One held in Ahmedabad for selling urea fertilizer; 1188 bags seized
- MEA Jaishankar visits National Maritime Heritage Complex, Lothal
- ACB Gujarat nabs Dy Mamlatdar, aide in bribe case in decoy trap
- Locals object to public preaching by missionaries in Ukai; video goes viral
- Illegal properties of bootleggers bulldozed in Ahmedabad
- Over 61 lakh rural citizens benefit from Digital Seva Setu in 2 years: Gujarat govt
- Gujarat govt approves DA hike under 6th & 7th Pay Commissions; over 9 lakh to benefit